Clinical trials - Press Releases

Date	Title	Company
26-Jan-2023	Cancer cells shrink or super-size to survive	The Institute of Cancer Research
25-Jan-2023	Cell Therapy Market is estimated to be US$ 19.6 billion by 2030 with a CAGR of 13.1% during the forecast period	prophecy
20-Jan-2023	The Lancet Neurology publishes results from Minoryx Therapeutics Phase 2/3 ADVANCE clinical trial of leriglitazone in X-linked Adrenoleukodystrophy	Minoryx Therapeutics
19-Jan-2023	Trial and Error - do our clinical trials match the ages of those who need medicines most?	International Longevity Centre (ILC)
19-Jan-2023	Servier and Taiho Oncology Present Overall Survival Data for Trifluridine/Tipiracil (LONSURF®) In Combination With Bevacizumab in Patients With Refractory Metastatic Colorectal Cancer at 2023 ASCO Gastrointestinal Cancers Symposium	Servier and Taiho Oncology
18-Jan-2023	Clinical trial gives terminal cancer patient new lease of life	The Christie
18-Jan-2023	AC Immune Partner Life Molecular Imaging Initiates Phase 3 Study of Tau PET Diagnostic PI-2620 for Alzheimer’s Disease	AC Immune
18-Jan-2023	Moderna Announces mRNA-1345, an Investigational Respiratory Syncytial Virus (RSV) Vaccine, Has Met Primary Efficacy Endpoints in Phase 3 Trial in Older Adults	Moderna
18-Jan-2023	Spectral MD (SMD.L*): Interim results from DFU trial shows improvement in DeepView diagnostic accuracy	Spectral MD
17-Jan-2023	Greenphire Appoints Owen Newman as Chief Financial Officer to Accelerate Company Growth	Greenphire
17-Jan-2023	UK ATMP Clinical Trials Database 2022: Number of Advanced Therapy Medicinal Product clinical trials in the UK continues to increase year-on-year	The Cell and Gene Therapy Catapult (CGT Catapult)
17-Jan-2023	SolasCure announces publication of toxicology and pre-clinical research programme as final patient is enrolled into pivotal clinical trial	SolasCure
17-Jan-2023	ImmunOs Therapeutics Receives Regulatory Approval for First-In-Human Trial of IOS-1002	ImmunOs Therapeutics
11-Jan-2023	HighTide Therapeutics Announces First Patient Dosed in Phase 2b Clinical Study Evaluating HTD1801 in NASH (the CENTRICITY study)	HighTide Therapeutics Inc.
11-Jan-2023	BioXcel Therapeutics Announces Promising Top-Line Results from Phase 2 Trial of BXCL701 in Aggressive Form of Rare Prostate Cancer	BioXcel Therapeutics
11-Jan-2023	Zenas BioPharma Announces First Patient Dosed in Phase 3 Clinical Study of Obexelimab for the Treatment of Immunoglobulin G4-Related Disease (IgG4-RD)	Zenas BioPharma
11-Jan-2023	UK independent clinical trial sites running research on new medicines continue to prosper despite the decline at NHS sites	Panthera
11-Jan-2023	Avance Clinical Celebrates GlobalReady Success as more than 40 Biotech Clients Enter Program	Avance Clinical
11-Jan-2023	Ethics Approval granted for significant Ultra Pure Synthetic CBD Phase III Efficacy Clinical Trial	Chanelle McCoy Health
10-Jan-2023	Phastar enhances Data Visualization and Analytics solution through acquisition of S-Cubed ApS, adds capability in Denmark	Phastar